ALCOHOL
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 46.0 | -0.0 | 1 | 1 | 20.0 | 0 | 1.0 |
- CAS
- 64175
- UNII
- 3K9958V90M
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Dental | Gel | 1.8% |
| Dental | Paste | |
| Dental | Solution | 11.34% |
| Extracorporeal | Solution | 5% |
| Im - Iv | Injectable | 10% |
| Im - Iv | Injection | 11% |
| Im - Iv | Injection | 20% |
| Im - Iv | Injection | 10% |
| Im - Iv | Solution, Injection | 10% |
| Im - Iv - Sc | Injection | 6.1% |
| Im - Iv - Sc | Injection | 4.93% |
| Inhalation | Aerosol, Metered | 95.89% |
| Inhalation | Aerosol, Metered | 34.55% |
| Inhalation | Aerosol, Spray | 33% |
| Inhalation | Aerosol, Spray | 32.9% |
| Inhalation | Solution | 25% |
| Intracavitary | Injection | |
| Intramuscular | Injection | 12% |
| Intramuscular | Injection | 10% |
| Intramuscular | Injection | |
| Intramuscular | Injection, Microspheres | |
| Intramuscular | Liquid | 10% |
| Intramuscular | Solution, Injection | 10% |
| Intravascular | Injection | |
| Intravenous | Injectable | 34.5%W/W |
| Intravenous | Injectable | 10% |
| Intravenous | Injection | 49% |
| Intravenous | Injection | 33.2% |
| Intravenous | Injection | 3160MG |
| Intravenous | Injection | |
| Intravenous | Liquid | 10% |
| Intravenous | Powder, For Injection Solution | |
| Intravenous | Solution, Concentrate | 39.46% |
| Intravenous | Solution, Injection | 68% |
| Intravenous | Solution, Injection | 39.5% |
| Intravesical | Solution | 50% |
| Iv - Sc | Injection | 0.95% |
| Iv(Infusion) | Injectable | 23% |
| Iv(Infusion) | Injection | 80% |
| Iv(Infusion) | Injection | 5ML |
| Iv(Infusion) | Powder, For Injection Solution, Lyophilized | 0.04% |
| Iv(Infusion) | Solution, Concentrate | |
| Iv(Infusion) | Solution, Injection | 49.7% |
| N/a | Not Applicable | |
| Nasal | Aerosol | 2% |
| Nasal | Aerosol, Metered | 0.7% |
| Nasal | Solution | |
| Ophthalmic | Solution | 1.4% |
| Ophthalmic | Solution | 0.5% |
| Oral | Aerosol, Metered | 0.0001% |
| Oral | Aerosol, Metered | 0.47% |
| Oral | Capsule | 2.84MG |
| Oral | Capsule | 200MG |
| Oral | Capsule | |
| Oral | Capsule, Delayed Action | |
| Oral | Capsule, Enteric Coated Pellets | |
| Oral | Capsule, Extended Release | |
| Oral | Capsule, Hard Gelatin | |
| Oral | Capsule, Soft Gelatin | 15.36MG |
| Oral | Capsule, Soft Gelatin | 159.6MG |
| Oral | Capsule, Sustained Action | |
| Oral | Concentrate | 71.6% |
| Oral | Concentrate | 0.00003% |
| Oral | Emulsion | |
| Oral | Granule, For Oral Suspension | |
| Oral | Inhalation | 0.13% |
| Oral | Liquid | 5% |
| Oral | Liquid | 10.21%W/V |
| Oral | Pellet | |
| Oral | Solution | 35.63% |
| Oral | Solution | 3% |
| Oral | Solution, Concentrate | 10% |
| Oral | Solution, Elixir | 4.25% |
| Oral | Solution, Elixir | 50% |
| Oral | Solution, Elixir | 21.34% |
| Oral | Solution, Liquid, Concentrate, Oral | 15.07% |
| Oral | Solution, Syrup | 0.05% |
| Oral | Suspension | 52% |
| Oral | Suspension | 1% |
| Oral | Suspension | |
| Oral | Syrup | 55% |
| Oral | Syrup | 5.8% |
| Oral | Syrup | 1.4% |
| Oral | Syrup | 0.5% |
| Oral | Tablet | 196MG |
| Oral | Tablet | 3MG |
| Oral | Tablet | 0.24MG |
| Oral | Tablet (Immed./comp. Release), Coated | |
| Oral | Tablet (Immed./comp. Release), Film Coated | |
| Oral | Tablet, Coated | |
| Oral | Tablet, Controlled Release | |
| Oral | Tablet, Delayed Action, Enteric Coated | 71.5MG |
| Oral | Tablet, Extended Release | 296MG |
| Oral | Tablet, Film Coated | |
| Oral | Tablet, Film Coated | 0.75MG |
| Oral | Tablet, For Suspension | |
| Oral | Tablet, Orally Disintegrating | |
| Oral | Tablet, Repeat Action | |
| Oral | Tablet, Sustained Action | |
| Oral | Wafer | |
| Oral-21 | Tablet | |
| Oral-28 | Tablet | |
| Oral-28 | Tablet, Film Coated | |
| Photopheresis | Solution | 5% |
| Rectal | Gel | 22.45% |
| Rectal | Suspension | 0.35% |
| Respiratory (Inhalation) | Aerosol, Metered | 10% |
| Respiratory (Inhalation) | Solution, For Inhalation | 0.08% |
| Route Not Given | Dosage Form Not Given | |
| Route Not Given | Solution, Injection | |
| Sublingual | Spray | 0.96% |
| Sublingual | Spray | 49.6% |
| Sublingual | Spray, Metered | 0.95% |
| Sublingual | Tablet | 0.001MG |
| Topical | Aerosol | 68% |
| Topical | Aerosol | 68.5% |
| Topical | Emulsion, Aerosol Foam | 58.21% |
| Topical | Emulsion, Aerosol Foam | 60.43% |
| Topical | Emulsion, Cream | |
| Topical | Gel | 84.95% |
| Topical | Gel | 94.78% |
| Topical | Gel | 96.94% |
| Topical | Lotion | 11.79%W/W |
| Topical | Lotion | |
| Topical | Lotion | 25% |
| Topical | Patch | |
| Topical | Powder, For Solution | |
| Topical | Shampoo | 10%W/W |
| Topical | Solution | 91.07% |
| Topical | Solution | 77% |
| Topical | Solution | 60.16% |
| Topical | Solution, Liquid | 25% |
| Topical | Spray | 49.25% |
| Topical | Swab | |
| Transdermal | Film, Controlled Release | 358.7MG |
| Transdermal | Film, Controlled Release | 250MG |
| Transdermal | Gel | 78.35% |
| Transdermal | Gel | 74% |
| Transdermal | Patch, Controlled Release | |
| Transdermal | Solution | 60.25% |
| Transdermal | Spray | |
| Vaginal | Tablet |